semaglutide compound lawsuit versions of GLP-1 drugs for weight loss halted by FDA Ozempic® Lawsuit | July 2026

(30) Rapid weight loss and volume shifts may contribute to perioperative hemodynamic instability, particularly in older or higher-risk patients

[4] As a result, GLP-1 agonists are contraindicated in individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2), a genetic disorder that increases the risk of certain types of tumors

Pain, redness, warmth to touch, swelling, or purulent (white, milky, creamy, pus-like) discharge at the injection site may indicate an infection and should be promptly reported to a healthcare provider

Your Next Step We work with patients looking for Medical Weight Loss in Grimes, IA , and Medical Weight Loss in West Des Moines, IA , and we keep the experience personal

A study found that while the drug is effective in weight management throughout therapy, discontinuing use will result in the patient regaining weight